HEALTH

GSK’s new Flonase already a top allergy seller

BY Michael Johnsen

NEW YORK — The true allergy tsunami this year is GlaxoSmithKline's new allergy remedy Flonase, which has already generated almost $100 million in its first 16 weeks on shelf and rocketed to the top of the cough/cold/sinus/allergy liquids brand list as sold across total U.S. multi-outlet, according to IRI figures. 
 
That $100 million lift to GSK's Consumer Healthcare business accounted for half of the division's 24% growth in quarterly sales, Simon Dingemans, GSK CFO, recently told analysts earlier in May. 
 
For the 12 weeks ended May 17, Flonase sales were more than double those of competitor corticosteroid nasal spray Nasacort Allergy 24HR and the GSK brand is not likely to face store brand competition anytime soon. 
 
Perrigo president and CEO Joseph Papa told analysts in February, at the time Flonase launched, that he was unsure GSK could maintain its three-year exclusivity on Flonase beyond specific claims for allergy eyes. However, Perrigo had no immediate plans to introduce a store brand Flonase.
 
“As to how it’s going to play out between that time, whether or not we want to go to the market with Flonase prior to the expiration of the allergic eye data … that’s unclear at this time,” he said. “So right now, we are not planning for our Flonase product to get to the market [in] 2015," he added. "We are still working with the regulatory side.”

keyboard_arrow_downCOMMENTS

Leave a Reply

P.Medhane says:
Sep-29-2016 01:29 am

Nice article…Flonase market is booming now. You can get its Market Manufactures and Key Statistics Analysis @ https://goo.gl/4GMCFQ

TRENDING STORIES

HEALTH

GoJo increases manufacturing capacity on anticipated growth

BY Michael Johnsen

AKRON, Ohio  – GoJo announced Friday that it has agreed to lease 1.3 million square feet of space in Wooster, Ohio, which will be used to expand manufacturing and distribution operations. The GoJo Wooster Campus is in addition to the GoJo headquarters in Akron, Ohio, manufacturing and distribution in Cuyahoga Falls, Ohio, and operations worldwide including those in the United Kingdom, Australia, Brazil, Canada, Japan, Mexico and France.
 
"GoJo expansion has been consistent overtime as our business has grown," said Mark Lerner, GoJo president and COO. "We are building capacity in Wooster to accommodate anticipated future growth. We look forward to creating new jobs here for Northeast Ohioans and maintaining our commitment to helping this region grow."
 
It will take the next six months to a year to update the infrastructure of the facilities and begin operations in Wooster, the company reported. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Study: Pharmacists positively impact diabetes health

BY Michael Johnsen

THOROFARE, N.J. – Pharmacists caring for underserved patients with suboptimally controlled type 2 diabetes were more adherent to their medications and had better glycemic control than those who did not have a pharmacist in their care team, according to a recent report in the journal The Diabetes Educator, Healio reported Wednesday
 
Consuelo Wilkins of Vanderbilt University Medical Center and colleagues conducted a retrospective review of 100 patient records to determine the effect of pharmacist-directed medication therapy management.
 
“Findings from this study may inform the development of metrics to more systematically assess the effects of pharmacist-directed MTM on health outcomes,” the researchers wrote. “These findings in a community health clinic population have broad implications for improving health care delivery and health outcomes in community-based settings.” 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES